EUVIMED · CrossrefZeitschrift
Journal of Medical Economics
ISSN 1369-6998 · Informa UK Limited
Neueste Artikel
Clinical benefits and cost saving of achieving composite treatment targets for type 2 diabetes – A modeling study
A five-year cost-consequence analysis of extended-use etonogestrel implant versus other contraceptives
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression
Economic burden of advanced non-small cell lung cancer (NSCLC): a systematic literature review
Modeling the cost-effectiveness of the next-generation COVID-19 mRNA-1283 vaccine in the United States
Clinical and economic benefits of combined genetic and genomic testing strategies to guide treatment decisions for patients with HR+/HER2– breast cancer in the US
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors
Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent β -thalassemia in the United States
The financial impact of surgical interventions for benign prostatic hyperplasia within a single NHS trust
Uncovering the full economic impact of biosimilars: a “would have spent” counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016–2025
Comparison of 1-year costs of commercially insured patients with severe aortic stenosis undergoing surgical vs. transcatheter aortic valve replacement
Pharmacists’ perspectives on efficiencies and other benefits of combination influenza/COVID-19 vaccination
Cost-effectiveness of onabotulinumtoxinA versus topiramate in chronic migraine in the US: an economic analysis of the FORWARD randomized trial
Overcoming barriers for expanding market access to follow-on biologics in lower-middle-income countries
Cost-utility analysis of surgical revascularization versus conservative management for adult moyamoya disease patients with posterior hemorrhage in Japan
Indirect treatment comparisons of nusinersen versus onasemnogene abeparvovec-brve in treatment-naïve and -experienced spinal muscular atrophy patients
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada
Cost-effectiveness of outpatient COVID-19 antiviral treatment with nirmatrelvir/ritonavir versus usual care in Swedish patients with various risk factors
US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines
Cost-effectiveness analysis of regorafenib dose optimization for refractory metastatic colorectal cancer
Use of external data to inform overall survival extrapolation in NICE technology appraisals for oncology drugs
Association between timing of adjunctive brexpiprazole initiation and healthcare resource use and costs in major depressive disorder
The evolving burden of obesity in the US: a novel population-level system dynamics approach
Comparison of utilization and total medicare fee-for-service expenditures for subcutaneous versus intravenous versions of a select group of therapies
Clinical and economic impact of ventricular assist device infections: a real-world claims analysis
Why are digital health policies crucial?
The economic burden of Ebola virus disease: a review and recommendations for analysis
Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer
EUVIMED